Management of recurrent hyperthyroidism in patients with Graves’ disease treated by subtotal thyroidectomy

作者: Kiminori Sugino , T. Mimura , O. Ozaki , H. Iwasaki , N. Wada

DOI: 10.1007/BF03349738

关键词:

摘要: If the aim of surgical treatment for Graves' disease is not permanent hypothyroidism, it difficult to avoid recurrent hyperthyroidism completely. The management hyperthyroidism, however, neither easy nor obvious. Improvement in sensitivity TSH assay has allowed diagnosis latent hyperthyroidism. Little known about clinical course We studied and outcome patients with treated by subtotal thyroidectomy. Between January 1988 August 1991, 1115 were surgery. Postoperative thyroid function was evaluated free T3, T4 measurements. One hundred seventy-five suppressed secretion at least 6 months categorized as having Eighty (45.1%) also had elevated hormone levels, (group 1). remaining 95 (54.9%) normal levels values 2). In group 1, 58 antithyroid drug (ATD), 12 iodine 10 radioiodine (RI). Remission obtained 22 (11 ATD, 1 Ri). On other hand, 2 followed up without medication, spontaneous remission observed 21 theln (22.1%). It induce overt ATD or iodine. contrast could be some postoperative

参考文章(19)
Lewis E. Braverman, Nilima A. Patwardhan, Simona Rossi, Matthew Moront, Sudha Rao, Surgery still has a role in Graves' hyperthyroidism. Surgery. ,vol. 114, pp. 1108- 1113 ,(1993) , 10.5555/URI:PII:003960609390330G
David V. Feliciano, Everything you wanted to know about Graves' disease. American Journal of Surgery. ,vol. 164, pp. 403- 411 ,(1992) , 10.1016/S0002-9610(05)81170-5
P. TAELMAN, J. M. KAUFMAN, X. JANSSENS, H. VANDECAUTER, A. VERMEULEN, Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clinical Endocrinology. ,vol. 33, pp. 107- 117 ,(1990) , 10.1111/J.1365-2265.1990.TB00471.X
YUJI NAGAYAMA, MOTOMORI IZUMI, SHIGENOBU NAGATAKI, The management of hyperthyroidism due to Graves' disease in Japan in 1988 Endocrinologia Japonica. ,vol. 36, pp. 299- 314 ,(1989) , 10.1507/ENDOCRJ1954.36.299
Takahiro Okamoto, Yoshihide Fujimoto, Takao Obara, Yukio Ito, Motohiko Aiba, Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease World Journal of Surgery. ,vol. 16, pp. 690- 695 ,(1992) , 10.1007/BF02067359
TERRENCEM DIAMOND, LIZA NERY, IAN HALES, A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. ,vol. 72, pp. 1184- 1188 ,(1991) , 10.1210/JCEM-72-6-1184
Benedetto Busnardo, M. E. Girelli, D. Rubello, C. Eccher, C. Betterle, Long term thyroid function after subtotal thyroidectomy for Graves’ disease Journal of Endocrinological Investigation. ,vol. 11, pp. 371- 374 ,(1988) , 10.1007/BF03349057
Vitaya Sridama, Maureen McCormick, Edwin L. Kaplan, Renee Fauchet, Leslie J. DeGroot, Long-Term Follow-up Study of Compensated Low-Dose 131I Therapy for Graves' Disease The New England Journal of Medicine. ,vol. 311, pp. 426- 432 ,(1984) , 10.1056/NEJM198408163110702